Carus Bio
PrivateLast Round
VC Round
Apr 1, 2025
Total Funding Raised
$8.85M
Company Overview
Carus Bio operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a VC Round in April 2025.
Carus Bio is a biotechnology company that develops a drug delivery platform, BioDrone™, based on cell-derived vesicles for in vivo CAR-T therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carus Bio Comparables
Compare Carus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ILIAS Biologics Inc. | 87% | |
| Evox Therapeutics | 87% | |
| VesiCURE Therapeutics | 80% |
For institutional investors. Book with your work email.
Carus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2025 | ||||
| Series B | Aug 27, 2019 | ||||
| Series A | Sep 30, 2016 |
For institutional investors. Book with your work email.
Carus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| (주)스마트앤그로스 | VC Round |
| DAYLI Partners | Series B |
| KCLAVIS Investment | Series B |
| The Wells Investment | Series B |
| QUAD Investment Management | Series B |
| InterValue Partners | Series B |
| STIC Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Raised a VC Round with (주)스마트앤그로스 as an investor.
- Aug 27, 2019
$9M round with participation from KCLAVIS Investment and QUAD Investment Management.
For institutional investors. Book with your work email.
Carus Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Carus Bio's valuation, stock price, and market status.
Is Carus Bio a public or private company?
Carus Bio is a private company.
What is the current stock price of Carus Bio?
Carus Bio is a private company, so its shares have no public market price. Caplight tracks Carus Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carus Bio worth (valuation)?
Valuation information for Carus Bio is not publicly available.
Can I buy Carus Bio stock?
Carus Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carus Bio's last funding round?
Carus Bio's most recent funding round was VC Round on April 1, 2025.
Who are the main investors in Carus Bio?
Key investors in Carus Bio include (주)스마트앤그로스, DAYLI Partners, KCLAVIS Investment, The Wells Investment, QUAD Investment Management.
Will Carus Bio IPO soon?
No public IPO plans have been announced for Carus Bio.
How can I track Carus Bio secondary market activity?
Caplight tracks bids, offers, and trades in Carus Bio's shares on secondary markets.